Clot-busting drugs linked to increased mortality in the very elderly.
Levenson
Deborah
D
D000367:Age Factors; D000368:Aged; D000572:American Heart Association; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D016330:Frail Elderly; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013300:Streptokinase / Q000009:adverse effects*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000401:mortality*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*; D016896:Treatment Outcome; D014481:United States
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator